What Were The Results Of The Initial Animal Testing For Cryolipolysis? Key Findings On Selective Fat Reduction

The initial animal testing for cryolipolysis demonstrated that fat cells could be successfully and selectively destroyed through controlled cooling. Conducted in 2007 using a cooling device on pigs, the tests resulted in an approximate 1/2 inch reduction in the fat layer of the treated areas. Crucially, this reduction occurred without causing any damage to the overlying skin, proving the safety of the mechanism.

The core validation from these 2007 trials was the discovery of "selective destruction." The study proved that it is possible to trigger cell death in fat tissue significantly enough to reduce volume while leaving the surrounding skin structure completely unharmed.

The Mechanics of the 2007 Trials

Successful Fat Layer Reduction

The primary objective of the 2007 study was to determine if a cooling device could effectively target adipose (fat) tissue.

The results were measurable and significant. The treated pigs experienced an approximate 1/2 inch reduction in the fat layer. This provided the necessary quantitative data to prove that cooling could physically reduce fat volume.

Safety and Skin Preservation

Equally important to the fat reduction was the safety profile observed during the tests.

The study confirmed that the cooling process did not harm the epidermis or dermis. The overlying skin remained intact, validating that the device could target depth without compromising the surface barrier.

The Biological Context

The Phenomenon of Cold Susceptibility

The success of the animal testing was based on a biological principle known as cold-induced fat necrosis.

This concept originated from historical observations of young children who developed inflammation in fat tissue after holding popsicles against their cheeks. While the fat tissue reacted, the skin remained normal.

Why the Concept Works

The popsicle observation led to the hypothesis that fat cells are significantly more susceptible to cold injury than other tissue types.

The 2007 pig study confirmed this hypothesis in a controlled environment. It demonstrated that lipid-rich cells crystallize and die at temperatures that do not injure water-rich cells, such as skin, nerves, and muscle.

Understanding the Limitations

The Scope of Reduction

While the tests were successful, it is important to contextualize the result of a 1/2 inch reduction.

This amount represents a contouring effect rather than massive weight loss. The technology is designed for targeted reduction of specific fat pockets, not the elimination of all body fat in an area.

Translation to Human Application

The 2007 tests provided a "proof of concept" using porcine models.

While pig skin is physiological similar to human skin, these initial results served as a baseline for safety and efficacy, rather than a guarantee of identical results in every human clinical scenario.

Interpreting the Data for Clinical Use

To understand how these early results apply to modern treatments, consider your specific goals:

If your primary focus is safety: The critical takeaway is that the procedure targets fat cells specifically, sparing the skin and surrounding tissues from cold injury.
If your primary focus is efficacy: The key takeaway is that the technology is proven to physically reduce the fat layer by a measurable amount (approx. 1/2 inch) in treated areas.

These initial animal trials successfully bridged the gap between accidental observation and a controlled, effective medical procedure.

Summary Table:

Key Metric	2007 Study Results	Clinical Significance
Fat Reduction	Approx. 1/2 inch reduction	Quantitative proof of fat layer thinning
Skin Safety	No damage to epidermis/dermis	Validates safety of selective cooling
Biological Basis	Cold-induced fat necrosis	Fat cells are more cold-susceptible than skin
Trial Model	Porcine (Pig) subjects	Physiological baseline for human application
Primary Outcome	Selective destruction	Targeted fat loss without surrounding tissue injury

Elevate Your Clinic’s Contouring Results with BELIS

As the initial trials proved, cryolipolysis is a powerful tool for non-invasive fat reduction. BELIS provides professional-grade medical aesthetic equipment designed to bring these proven results to your premium salon or clinic. Our advanced Cryolipolysis and RF Cavitation systems ensure high safety standards and measurable body sculpting outcomes for your clients.

Beyond body contouring, our portfolio includes:

Advanced Laser Systems: Diode Hair Removal, CO2 Fractional, Nd:YAG, and Pico lasers.
Facial & Skin Care: Hydrafacial systems, Skin Testers, and Microneedle RF.
Anti-Aging & Sculpting: HIFU, EMSlim, and specialized hair growth machines.

Ready to integrate industry-leading technology into your practice? Contact us today to discuss your equipment needs.